Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Reuse of single-use devices

This article was originally published in The Gray Sheet

Executive Summary

Senate Health Committee intends to hold a hearing on the contentious issue to gather information, possibly before the August congressional recess, according to committee staffers. As of late July 16, the committee had yet to receive FDA's response to its request for details regarding the agency's plans for regulating reprocessed single-use devices (1"The Gray Sheet" July 12, In Brief)

You may also be interested in...

Reuse of single-use devices

Senate Health Committee Chairman James Jeffords (R-Vt.) and panel member Bill Frist (R-Tenn.) request in a July 2 letter to FDA Commissioner Jane Henney that the agency provide by July 12 an explanation as to the "current activities...being taken by FDA to ensure that all reprocessed single-use devices are safe and effective for their intended use." The senators also ask FDA to explain its "future address this issue, including a detailed timeline for full implementation." The agency also is requested to specify whether it believes "new legislative authority is necessary for FDA to require" registration of and premarket submissions from device reprocessors. In addition, FDA is asked to supply the "total number" and a "complete list" of reprocessed, single-use devices

E.l.f. Has A Go At Twitch Crowd, Hitching Wagon To #Loserfruit

The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.

An Oversupply Of COVID Antibody Treatments? Multiple Monoclonal Products Raise Potential For Errors

As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts